Skip to content
Monday, November 9, 2026
Smooth Corner Deals

The Zimbabwean Government Turns Down ‘Lopsided’ American Health Aid Deal Over Data Fears

Medical aid illustration
The offered US financial assistance was aimed at initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has rejected a significant American healthcare agreement valued at $367m (272 million pounds) over five years due to the United States' demand for sensitive information.

This rejection came to light following a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the deal was "skewed".

An official spokesperson has since stated that the US was seeking genetic material for scientific study and commercial purposes while refused to share the resulting advantages from any future vaccines.

"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.

A medical body in Zimbabwe has called for continued dialogue to secure a agreement suitable to both sides so the country's vital HIV programme can continue.

Wider Implications

This development follows a similar case in neighbouring Kenya, where a court halted a related deal with the US following legal challenges were filed about the security of Kenyans' medical information.

After returning to the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.

USAID had managed aid for the US government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost openness and responsibility.

Based on reports, 16 nations in Africa have so far agreed to similar health pacts, constituting over $18.3bn of fresh investment.

Specifics of the Rejected Deal

The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this cooperation would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment through American-funded programmes," the Ambassador added.

However, official spokesman Nick Mangwana said the arrangement was "unequal".

"Zimbabwe was being asked to share its genetic material and health information indefinitely, with no corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.

"Effectively, our country would provide the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our people if a new disease outbreak arise."

National Interest and International Frameworks

Mangwana further noted that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were undermining systems previously established through the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with potential global health emergencies.

"This mechanism is designed to guarantee that when a nation contributes its data, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the resources to create them."

Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We welcome further dialogue with our American counterparts on how subsequent co-operation might be designed in a manner that respects the sovereignty and interests of each country."

Health Experts Response

A leading public health body said it acknowledged the official position, but suggested that talks should continue given that much of the country's HIV programmes were funded by international support.

"Where technical issues exist, such as those relating to data governance or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," the group said.

This impasse highlights the complex tensions between receiving vital international aid and safeguarding local interests in an ever more data-driven world.

The writer

Justin Underwood

Lena Visser is a seasoned online shopper and deals enthusiast who loves sharing her finds.

Smooth Corner Deals

Type to search articles.